Project
Immunogenicity of multi-epitope transmission-blocking vaccine candidates based on Aedes mosquito saliva proteins
From January 2022 to August 2024, a total of 45,652 cases and 1492 deaths were reported in 12 African countries.
Publication
Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an effective HIV vaccine
Van Regenmortel Marc H. V. 2012. Requirements for empirical immunogenicity trials, rather than structure-based design, for developing an eff...
